APAC Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

APAC Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Asia-Pacific Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (China, India, Japan, South Korea, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam and Rest of Asia-Pacific) Industry Trends and Forecast to 2030

Market Definition:

Colorectal cancer starts in the colon or the rectum. Depending on where they start, these cancers can also be called colon cancer or rectal cancer. Colon cancer and rectal cancer are often grouped because they have many features in common. Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Sometimes it is called colon cancer, short. The colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus.

Sometimes abnormal growths, called polyps, form in the colon or rectum. Over time, some polyps may turn into cancer. Screening tests can find polyps so they can be removed before becoming cancer. Screening also helps find colorectal cancer early, when treatment works best.

Market Segmentation:

Asia-Pacific throat cancer diagnostics market is categorized into six notable segments such as product type, test type, stages, cancer type, age group, and end user.
• On the basis of product type, the Asia-Pacific colorectal cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the Asia-Pacific colorectal cancer diagnostics market is segmented into stool examination, imaging tests, biopsy, blood tests, tumor markers and others
• On the basis of stages, the Asia-Pacific colorectal cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV
• On the basis of cancer type, the Asia-Pacific colorectal cancer diagnostics market is segmented into adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others
• On the basis of age group, the Asia-Pacific colorectal cancer diagnostics market is segmented into pediatric, adult, and geriatric
• On the basis of end user, the Asia-Pacific colorectal cancer diagnostics market is segmented into hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, academic institutes, and others



Market Players

Some of the major players operating in the Asia-Pacific colorectal cancer diagnostics market are:
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Quest Diagnostics Incorporated
• CANON MEDICAL SYSTEMS CORPORATION
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• FUJIFILM Corporation
• Agilent Technologies, Inc.
• BD
• Siemens Healthcare GmbH
• Abbott
• Neusoft Corporation
• BioFire Diagnostics
• Myriad Genetics Inc.
• QIAGEN
• Hologic, Inc.
• Time Medical Holding.
• PlexBio
• GE HealthCare.
• MinFound Medical Systems Co., Ltd
• Medonica Co. Ltd
• Beijing O&D Biotech Co., Ltd.